SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H.M. Savignac, M. Tramullas, B. Kiely, T.G. Dinan, J.F. Cryan, Bifidobacteria modulate cognitive processes in an anxious mouse strain, Behavioural Brain Research, 2015, 287, 59

    CrossRef

  2. 2
    Edgardo Falcon, Kaitlyn Maier, Shivon A. Robinson, Tiffany E. Hill-Smith, Irwin Lucki, Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice, Psychopharmacology, 2015, 232, 5, 907

    CrossRef

  3. 3
    Fabricio A. Moreira, Bianca Jupp, David Belin, Jeffrey W. Dalley, Endocannabinoids and striatal function, Behavioural Pharmacology, 2015, 26, 59

    CrossRef

  4. 4
    Rubing Zhao-Shea, Steven R. DeGroot, Liwang Liu, Markus Vallaster, Xueyan Pang, Qin Su, Guangping Gao, Oliver J. Rando, Gilles E. Martin, Olivier George, Paul D. Gardner, Andrew R. Tapper, Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal, Nature Communications, 2015, 6, 6770

    CrossRef

  5. 5
    Lílian Danielle Paiva Magno, Aldo Fontes, Beatriz Maria Necy Gonçalves, Amauri Gouveia, Pharmacological study of the light/dark preference test in zebrafish (Danio rerio): Waterborne administration, Pharmacology Biochemistry and Behavior, 2015, 135, 169

    CrossRef

  6. 6
    Karen A Scott, Alan E Hoban, Gerard Clarke, Gerard M Moloney, Timothy G Dinan, John F Cryan, Thinking small: towards microRNA-based therapeutics for anxiety disorders, Expert Opinion on Investigational Drugs, 2015, 24, 4, 529

    CrossRef

  7. 7
    Fabian F. Sweeney, Olivia F. O'Leary, John F. Cryan, Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice, Neuropharmacology, 2014, 81, 303

    CrossRef

  8. 8
    Paul McGonigle, Animal models of CNS disorders, Biochemical Pharmacology, 2014, 87, 1, 140

    CrossRef

  9. 9
    Jéssica Pereira Costa, Guilherme Antônio L. de Oliveira, Antônia Amanda C. de Almeida, Md.Torequl Islam, Damião Pergentino de Sousa, Rivelilson Mendes de Freitas, Anxiolytic-like effects of phytol: Possible involvement of GABAergic transmission, Brain Research, 2014, 1547, 34

    CrossRef

  10. 10
    H. M. Savignac, B. Kiely, T. G. Dinan, J. F. Cryan, Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice, Neurogastroenterology & Motility, 2014, 26, 11
  11. 11
    Despina E Ganella, Jee Hyun Kim, Developmental rodent models of fear and anxiety: from neurobiology to pharmacology, British Journal of Pharmacology, 2014, 171, 20
  12. 12
    N.A. Andrews, M. Papakosta, N.M. Barnes, Discovery of novel anxiolytic agents — The trials and tribulations of pre-clinical models of anxiety, Neurobiology of Disease, 2014, 61, 72

    CrossRef

  13. 13
    Andrew J Lawrence, John F Cryan, Found in translation? Commentary on a BJP themed issue about animal models in neuropsychiatry research, British Journal of Pharmacology, 2014, 171, 20
  14. 14
    Pradeep J Nathan, K Luan Phan, Catherine J Harmer, Mitul A Mehta, Edward T Bullmore, Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery, Current Opinion in Pharmacology, 2014, 14, 54

    CrossRef

  15. 15
    Adam D. Farmer, Holly A. Randall, Qasim Aziz, It's a gut feeling: How the gut microbiota affects the state of mind, The Journal of Physiology, 2014, 592, 14
  16. 16
    Hyungwoo Nam, Sarah M. Clinton, Nateka L. Jackson, Ilan A. Kerman, Learned helplessness and social avoidance in the Wistar-Kyoto rat, Frontiers in Behavioral Neuroscience, 2014, 8,

    CrossRef

  17. 17
    A Lotan, T Lifschytz, A Slonimsky, E C Broner, L Greenbaum, S Abedat, Y Fellig, H Cohen, O Lory, G Goelman, B Lerer, Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders, Molecular Psychiatry, 2014, 19, 2, 243

    CrossRef

  18. You have free access to this content18
    Stella Koutsikou, Jonathan J. Crook, Emma V. Earl, J. Lianne Leith, Thomas C. Watson, Bridget M. Lumb, Richard Apps, Neural substrates underlying fear-evoked freezing: the periaqueductal grey–cerebellar link, The Journal of Physiology, 2014, 592, 10
  19. 19
    Amit Lotan, Michaela Fenckova, Janita Bralten, Aet Alttoa, Luanna Dixson, Robert W. Williams, Monique van der Voet, Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders, Frontiers in Neuroscience, 2014, 8,

    CrossRef

  20. 20
    Kevin K Ogden, Alpa Khatri, Stephen F Traynelis, Scott A Heldt, Potentiation of GluN2C/D NMDA Receptor Subtypes in the Amygdala Facilitates the Retention of Fear and Extinction Learning in Mice, Neuropsychopharmacology, 2014, 39, 3, 625

    CrossRef

  21. 21
    N Kokras, C Dalla, Sex differences in animal models of psychiatric disorders, British Journal of Pharmacology, 2014, 171, 20
  22. 22
    Allan V. Kalueff, Michael Nguyen, Testing anxiolytic drugs in the C57BL/6J mouse strain, Journal of Pharmacological and Toxicological Methods, 2014, 69, 2, 205

    CrossRef

  23. 23
    Nikolaos Pitsikas, The metabotropic glutamate receptors: Potential drug targets for the treatment of anxiety disorders?, European Journal of Pharmacology, 2014, 723, 181

    CrossRef

  24. 24
    Sarah Adams Schoenrock, Lisa M. Tarantino, Epigenetics in Psychiatry, 2014,

    CrossRef

  25. 25
    Richard M. O'Connor, Deepak R. Thakker, Markus Schmutz, Herman van der Putten, Daniel Hoyer, Peter J. Flor, John F. Cryan, Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse, Neuropharmacology, 2013, 72, 66

    CrossRef

  26. 26
    María Celeste Bigliani, María Celeste Rosso, Paula M. Zunino, Gustavo Baiardi, Andrés Alberto Ponce, Anxiogenic-like effects ofUncariatomentosa(Willd.) DC. aqueous extract in an elevated plus maze test in mice: a preliminary study, Natural Product Research, 2013, 27, 18, 1682

    CrossRef

  27. 27
    Lea R. Chioca, Marcelo M. Ferro, Irinéia P. Baretta, Sara M. Oliveira, Cássia R. Silva, Juliano Ferreira, Estela M. Losso, Roberto Andreatini, Anxiolytic-like effect of lavender essential oil inhalation in mice: Participation of serotonergic but not GABAA/benzodiazepine neurotransmission, Journal of Ethnopharmacology, 2013, 147, 2, 412

    CrossRef

  28. 28
    Ryan Y Wong, Sarah E Oxendine, John Godwin, Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment, BMC Genomics, 2013, 14, 1, 348

    CrossRef

  29. 29
    Vincenzo Micale, Vincenzo Di Marzo, Alexandra Sulcova, Carsten T. Wotjak, Filippo Drago, Endocannabinoid system and mood disorders: Priming a target for new therapies, Pharmacology & Therapeutics, 2013, 138, 1, 18

    CrossRef

  30. 30
    Fabian F. Sweeney, Olivia F. O’Leary, John F. Cryan, GABAB receptor ligands do not modify conditioned fear responses in BALB/c mice, Behavioural Brain Research, 2013, 256, 151

    CrossRef

  31. 31
    Christine M. Tenk, Martin Kavaliers, Klaus-Peter Ossenkopp, Neonatal treatment with lipopolysaccharide differentially affects adult anxiety responses in the light–dark test and taste neophobia test in male and female rats, International Journal of Developmental Neuroscience, 2013, 31, 3, 171

    CrossRef

  32. 32
    G Clarke, S Grenham, P Scully, P Fitzgerald, R D Moloney, F Shanahan, T G Dinan, J F Cryan, The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner, Molecular Psychiatry, 2013, 18, 6, 666

    CrossRef

  33. 33
    Markus Fendt, Michael Koch, Translational value of startle modulations, Cell and Tissue Research, 2013, 354, 1, 287

    CrossRef

  34. 34
    Timothy P. O’Leary, Rhian K. Gunn, Richard E. Brown, What are We Measuring When We Test Strain Differences in Anxiety in Mice?, Behavior Genetics, 2013, 43, 1, 34

    CrossRef

  35. You have free access to this content35
    A. Richard Green, Jeffrey K. Aronson, An agenda for UK clinical pharmacology: From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?, British Journal of Clinical Pharmacology, 2012, 73, 6
  36. 36
    R M O'Connor, T G Dinan, J F Cryan, Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression, Molecular Psychiatry, 2012, 17, 4, 359

    CrossRef

  37. 37
    John F. Cryan, Timothy G. Dinan, Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour, Nature Reviews Neuroscience, 2012, 13, 10, 701

    CrossRef

  38. 38
    J. F. Cryan, J. A. Bravo, T. G. Dinan, P. Forsythe, J. Bienenstock, Reply to McLean et al. and Burnet: The microbiome-gut-brain axis as a pathway toward next generation psychotropics, Proceedings of the National Academy of Sciences, 2012, 109, 4, E176

    CrossRef

  39. 39
    Alan M. Palmer, Mohammad S. Alavijeh, Translational CNS medicines research, Drug Discovery Today, 2012, 17, 19-20, 1068

    CrossRef

  40. 40
    Catherine Belzung, Maël Lemoine, Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression, Biology of Mood & Anxiety Disorders, 2011, 1, 1, 9

    CrossRef

  41. You have free access to this content41
    AR Green, J Gabrielsson, KCF Fone, Translational neuropharmacology and the appropriate and effective use of animal models, British Journal of Pharmacology, 2011, 164, 4